Generally, you may be a good candidate for GLP-1 therapy if: You have a body mass index (BMI) that falls within a certain range, typically 27 or higher with a weight-related health condition, or 30 or higher without one
These substances induce neurotoxicity through oxidative stress, excitotoxicity, and neuroinflammation, often resulting in cognitive and psychiatric impairments
your healthcare provider will determine the right maintenance dose for you based on your results and tolerance
(Daejeon, Korea)
Each escalation represents a meaningful increase in therapeutic effect, yet your PlexusDx monthly bill never rises because pricing is flat per compound, not per dose strength
IGF-1 receptor contributes to the malignant phenotype in research subjects and canine [PMID: 15095405] Laboratory literature summary: IGF-1 receptor contributes to the malignant phenotype in research subjects and canine oncology research models